S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Novus Therapeutics (NVUS) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
morningstar.com logoVivoryon Therapeutics NV VVY
morningstar.com - March 1 at 10:37 PM
money.usnews.com logoViking Therapeutics Inc
money.usnews.com - February 22 at 8:11 PM
seekingalpha.com logoCYT Cyteir Therapeutics, Inc.
seekingalpha.com - December 28 at 2:55 PM
finance.yahoo.com logoNovo Holdings invests in US$105 million Series C Funding of Alentis Therapeutics
finance.yahoo.com - May 11 at 10:47 AM
benzinga.com logoProQR Therapeutics Stock (NASDAQ:PRQR), Analyst Ratings, Price Targets, Predictions
benzinga.com - March 31 at 6:04 PM
finance.yahoo.com logoSales Revenue from CNS Therapeutics Market to Top US$ 142.1 Billion by 2026: Fact.MR Analysis
finance.yahoo.com - March 30 at 3:52 PM
proactiveinvestors.com logoChimeric Therapeutics welcomes “positive” feedback following pre-IND meeting with US FDA for Phase 1 CAR-T study
proactiveinvestors.com - March 29 at 8:06 AM
usnews.com logoEast Career Technical Academy
usnews.com - March 25 at 6:58 PM
usnews.com logoLas Vegas Academy of the Arts
usnews.com - March 25 at 6:58 PM
money.usnews.com logoPerspective Therapeutics Inc
money.usnews.com - February 22 at 3:24 PM
finance.yahoo.com logoOnychomycosis Therapeutics Market Size Worth US$ ~8,420.3 million , Globally, by 2030 at 6% CAGR
finance.yahoo.com - February 12 at 1:14 AM
Get Novus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVUS and its competitors with MarketBeat's FREE daily newsletter.

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

NVUS Media Mentions By Week

NVUS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVUS
News Sentiment

0.00

0.53

Average
Medical
News Sentiment

NVUS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVUS Articles
This Week

0

0

NVUS Articles
Average Week

Get Novus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVUS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NVUS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners